SCHEMBL20744772

SCHEMBL20744772

Nc1ncnc2c1c(Cc1cccc(Cl)c1)nn2C1CC(F)C1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRC P12931 12/20 0.60
CSNK1A1 P48729 1/20 0.53
CSNK1D P48730 1/20 0.53
CSNK1E P49674 1/20 0.53
AKT1 P31749 1/20 0.45
EGFR P00533 1/20 0.45
IGF1R P08069 1/20 0.45
RET P07949 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ABL1 P00519 2/20 0.44
PIK3CD O00329 1/20 0.40
BTK Q06187 1/20 0.40
RIPK2 O43353 1/20 0.40
LCK P06239 1/20 0.39
TEK Q02763 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20744770 1.00 SRC (0.60) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20744798 0.90 SRC (0.60) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20744781 0.90 SRC (0.60) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20744784 0.90 SRC (0.60) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20500111 0.89 SRC (0.65) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20500101 0.88 SRC (0.62) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL863906 0.88 SRC (0.64) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20744765 0.86 SRC (0.60) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20744808 0.85 SRC (0.55) SRCCSNK1A1CSNK1DCSNK1EAKT1
SCHEMBL20744809 0.85 SRC (0.55) SRCCSNK1A1CSNK1DCSNK1EAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3853230-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2021-07-28 EP disclosed
EP-3668875-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2020-06-24 EP disclosed
WO-2020061279-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2020-03-26 WO disclosed
WO-2019036001-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2019-02-21 WO disclosed